FDA to revise **vartis? Gilenya label to reflect brain infection risk
 

FDA to revise **vartis? Gilenya label to reflect brain infection risk
(Reuters) - The U.S. Food and Drug Administration said it will update the label of **vartis AG's multiple sclerosis drug, Gilenya, after cases of serious brain infections were linked with its use.
http://i2.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...Vk:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...Vk:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/xdgA62l_TAk